Síndrome de Schnitzler tratado con canakinumab / Schnitzler syndrome treated with canakinumab
Rev. argent. reumatolg. (En línea)
;
30(3): 34-37, 2019. ilus
Article
in Spanish
| LILACS, BINACIS
| ID: biblio-1117715
RESUMEN
El síndrome de Schnitzler es un raro trastorno caracterizado por rash urticariano crónico y gammapatía monoclonal, acompañado de fiebre intermitente, artralgias o artritis, dolor óseo y linfadenopatías, en el cual la interleuquina 1 (IL-1) tiene un papel preponderante. Se presenta el caso de un varón de 48 años que reúne criterios para síndrome de Schnitzler y que luego de fallar a múltiples tratamientos presenta respuesta exitosa a canakinumab
ABSTRACT
Schnitzler syndrome is a rare disorder characterized by chronic urticarial rash and monoclonal gammopathy, accompanied by intermittent fever, arthralgia or arthritis, bone pain and lymphadenopathy, in which interleukin 1 (IL-1) has a preponderant role. The case of a 48-year-old male who meets criteria for Schnitzler syndrome and who after failing too many treatments presents a successful response to canakinumab is presented here
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Therapeutics
/
Schnitzler Syndrome
Language:
Spanish
Journal:
Rev. argent. reumatolg. (En línea)
Journal subject:
Medicina Cl¡nica
/
Patologia
Year:
2019
Type:
Article
Affiliation country:
Argentina
Institution/Affiliation country:
Hospital San Martín/AR
Similar
MEDLINE
...
LILACS
LIS